Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Adverse drug reactionInosine triphosphate pyrophosphataseQ9BY32Not Available15167706; 15571265; 15973722
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityPurine nucleoside phosphorylaseP00491T781987818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityCytosolic 5'-nucleotidase 1AQ9BXI3Not Available7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vitello-intestinal duct remnant07.11.04.012; 03.04.04.0070.001436%Not Available
Fistula discharge15.03.02.015; 08.01.03.0690.003590%Not Available
Gastroenteritis norovirus11.05.22.001; 07.19.03.0170.001436%Not Available
Gastrointestinal viral infection11.05.04.016; 07.19.02.0110.001436%Not Available
Acquired gene mutation08.01.10.0020.001436%Not Available
Inflammatory marker increased13.09.02.0030.004308%Not Available
Mycobacterium tuberculosis complex test positive13.08.05.0040.001436%Not Available
Norovirus test positive13.08.03.0310.001436%Not Available
Epstein-Barr virus associated lymphoma16.28.01.003; 11.05.10.007; 01.15.01.0030.001311%Not Available
Faecal calprotectin increased13.05.02.0050.005744%Not Available
Intestinal fibrosis07.13.01.0130.005026%Not Available
Invasive ductal breast carcinoma21.05.01.021; 16.10.01.0130.000375%Not Available
Anal squamous cell carcinoma16.13.05.002; 07.21.05.0040.000375%Not Available
Small intestine adenocarcinoma16.13.13.001; 07.21.01.0150.000375%Not Available
Abdominal lymphadenopathy07.11.01.018; 01.09.01.0200.002872%Not Available
Large intestinal stenosis07.13.03.0040.021540%
Anorectal swelling07.03.03.0080.001436%Not Available
Phospholipidosis14.08.04.0250.002154%Not Available
Infantile haemangioma24.03.06.009; 16.02.01.0070.001436%Not Available
Gastrointestinal wall thickening07.01.06.0320.004308%Not Available
Kidney congestion20.02.03.015; 02.05.04.0170.000562%Not Available
Non-cirrhotic portal hypertension24.08.06.003; 09.01.06.0190.004308%Not Available
The 27th Page    First    Pre   27    Total 27 Pages